Evaluation of Novel Spectacles Intended for Myopia Management in a Short-Term Study

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age8-15
SponsorMyoptechs, Inc

About this trial

The primary objective of this study is to evaluate the visual acuity, wearability, and quality of vision with two novel multifocal glasses designs in habitual myopia control glasses wearers, in a non-dispensing study after short-term wear.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

8 - 15 years of age, inclusive.

Ability of the child to assent, and for one parent to provide permission to participate.

Had an eye examination within the past year.

Distance visual acuity of 20/25 (logMAR +0.10) or better in each eye with best corrected with sph/cyl subjective refraction.

Disqualifiers

Current report of active ocular inflammation or infection.

Astigmatism > 1.00 D in either eye

History of previous eye surgery

Trial design

Design model

Crossover

Treatments tested in this trial

  • Habitual myopia glasses

    Device

    Habitual myopia glasses of study P/905/25/MO

  • Myopia Glasses A

    Device

    Myopia glasses A of study P/905/25/MO

  • Myopia Glasses B

    Device

    Myopia glasses B of study P/905/25/MO

Treatment groups

20 Participants
are divided into 3 treatment groups
Group A: Habitual myopia glassesActive comparator 1 intervention
Group B: Myopia Glasses AExperimental treatment 1 intervention
Group C: Myopia Glasses BExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Binocular visual acuity

Binocular visual acuity with habitual myopia spectacle lens design and two test spectacle lens designs.

Time frame
20 minutes of wearing each lens design.

Secondary outcomes

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Myoptechs, Inc

Lead sponsor

University of Waterloo School of Optometry and Vision Science

Collaborator

This trial is not recruiting at the moment. You can still explore other options: